General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

R&D

The Novartis Vaccines Institute for Global Health (NVGH) in Siena, Italy, is a research institute established by Novartis in 2007. The NVGH was the first such initiative with a non-profit mission established by a major vaccine manufacturer. All vaccines developed by NVGH will also be provided at an affordable and accessible price to populations of developing countries.

Vaccine research NVGH test tubes
Vaccine research NVGH test tubes
Vaccines research at the NVGH
Vaccines research at the NVGH microscope
Vaccines research at the NVGH microscope
NVGH research
NVGH research

You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).